Establishment Labs Holdings Debt to Equity Ratio 2017-2024 | ESTA

Current and historical debt to equity ratio values for Establishment Labs Holdings (ESTA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Establishment Labs Holdings debt/equity for the three months ending December 31, 2024 was 4.14.
Establishment Labs Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.29B $0.05B 5.53
2024-09-30 $0.25B $0.03B 7.64
2024-06-30 $0.24B $0.05B 5.33
2024-03-31 $0.25B $0.06B 4.30
2023-12-31 $0.25B $0.02B 13.60
2023-09-30 $0.24B $0.03B 7.87
2023-06-30 $0.23B $0.06B 4.20
2023-03-31 $0.23B $-0.02B -14.09
2022-12-31 $0.22B $-0.01B -26.79
2022-09-30 $0.19B $0.00B 122.54
2022-06-30 $0.18B $0.02B 11.60
2022-03-31 $0.09B $0.05B 1.96
2021-12-31 $0.09B $0.05B 1.75
2021-09-30 $0.09B $0.06B 1.41
2021-06-30 $0.08B $0.07B 1.21
2021-03-31 $0.08B $0.07B 1.10
2020-12-31 $0.08B $0.08B 1.09
2020-09-30 $0.08B $0.08B 0.94
2020-06-30 $0.08B $0.08B 0.92
2020-03-31 $0.08B $0.09B 0.87
2019-12-31 $0.08B $0.04B 1.94
2019-09-30 $0.07B $0.04B 1.70
2019-06-30 $0.05B $0.05B 0.95
2019-03-31 $0.05B $0.06B 0.79
2018-12-31 $0.05B $0.07B 0.68
2018-09-30 $0.04B $0.08B 0.58
2018-06-30 $0.06B $0.00B 25.71
2018-03-31 $0.07B $-0.01B -7.74
2017-12-31 $0.06B $-0.01B -12.39
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.06B $-0.03B -2.12
Sector Industry Market Cap Revenue
Medical Medical Services $0.960B $0.166B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.189B 25.92
Elevance Health (ELV) United States $94.312B 12.17
CVS Health (CVS) United States $84.478B 10.50
Cencora (COR) United States $59.063B 20.54
Natera (NTRA) United States $21.643B 0.00
DiDi Global (DIDIY) China $20.379B 30.93
BioMerieux (BMXMF) France $15.263B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.707B 0.00
Solventum (SOLV) United States $11.330B 10.56
ICON (ICLR) Ireland $11.213B 10.42
CochLear (CHEOY) Australia $11.158B 0.00
Doximity (DOCS) United States $10.895B 56.66
Revvity (RVTY) United States $10.796B 18.58
Viatris (VTRS) United States $10.198B 3.25
Medpace Holdings (MEDP) United States $8.622B 22.90
Sonic Healthcare (SKHHY) Australia $8.157B 0.00
Avantor (AVTR) United States $8.136B 11.82
HealthEquity (HQY) United States $7.933B 39.03
Charles River Laboratories (CRL) United States $6.727B 13.18
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.028B 23.75
BrightSpring Health Services (BTSG) United States $4.015B 37.16
Sotera Health (SHC) United States $3.733B 21.21
Alignment Healthcare (ALHC) United States $3.071B 0.00
Surgery Partners (SGRY) United States $2.969B 34.06
Concentras Parent (CON) United States $2.803B 16.20
Organon (OGN) United States $2.277B 2.42
Premier (PINC) United States $2.111B 14.45
Ardent Health Partners (ARDT) United States $2.028B 8.66
Progyny (PGNY) United States $2.006B 44.19
GeneDx Holdings (WGS) United States $1.609B 63.01
PACS (PACS) United States $1.603B 0.00
GoodRx Holdings (GDRX) United States $1.454B 27.07
Agilon Health (AGL) United States $1.403B 0.00
Pediatrix Medical (MD) United States $1.233B 9.38
Teladoc Health (TDOC) United States $1.203B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
CareDx (CDNA) United States $0.822B 12.84
AMN Healthcare Services Inc (AMN) United States $0.749B 5.92
Embecta (EMBC) United States $0.725B 4.97
QDM (QDMI) Hong Kong, SAR China $0.671B 0.00
Nutex Health (NUTX) United States $0.649B 12.72
Auna S.A (AUNA) Luxembourg $0.518B 13.73
Sonida Senior Living (SNDA) United States $0.452B 0.00
InnovAge Holding (INNV) United States $0.440B 0.00
Enhabit (EHAB) United States $0.415B 34.17
LifeMD (LFMD) United States $0.364B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.347B 0.00
SBC Medicals (SBC) United States $0.332B 0.00
DocGo (DCGO) United States $0.245B 10.00
Oncology Institute (TOI) United States $0.208B 0.00
Performant Healthcare (PHLT) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.178B 0.00
Sera Prognostics (SERA) United States $0.090B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
So-Young (SY) China $0.084B 0.00
Ascend Wellness Holdings (AAWH) United States $0.084B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
ModivCare (MODV) United States $0.019B 6.75
KindlyMD (KDLY) United States $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00